Search results

    Filter results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 213
Number of items: 213
  • Open Access
    Gorter, J. A., Aronica, E., & van Vliet, E. A. (2019). The Roof is Leaking and a Storm is Raging: Repairing the Blood-Brain Barrier in the Fight Against Epilepsy. Epilepsy currents, 19(3), 177-181. https://doi.org/10.1177/1535759719844750
  • Open Access
    Ruffolo, G., Cifelli, P., Roseti, C., Thom, M., van Vliet, E. A., Limatola, C., Aronica, E., & Palma, E. (2018). A novel GABAergic dysfunction in human Dravet syndrome. Epilepsia, 59(11), 2106-2117. https://doi.org/10.1111/epi.14574
  • Open Access
    Broekaart, D. W. M., Anink, J. J., Baayen, J. C., Idema, S., de Vries, H. E., Aronica, E., Gorter, J. A., & van Vliet, E. A. (2018). Activation of the innate immune system is evident throughout epileptogenesis and is associated with blood-brain barrier dysfunction and seizure progression. Epilepsia, 59(10), 1931-1944. https://doi.org/10.1111/epi.14550
  • Open Access
    Korotkov, A., Broekaart, D. W. M., van Scheppingen, J., Anink, J. J., Baayen, J. C., Idema, S., Gorter, J. A., Aronica, E., & van Vliet, E. A. (2018). Increased expression of matrix metalloproteinase 3 can be attenuated by inhibition of microRNA-155 in cultured human astrocytes. Journal of neuroinflammation, 15, Article 211. https://doi.org/10.1186/s12974-018-1245-y
  • Open Access
    Drion, C. M., van Scheppingen, J., Arena, A., Geijtenbeek, K. W., Kooijman, L., van Vliet, E. A., Aronica, E., & Gorter, J. A. (2018). Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy. Journal of neuroinflammation, 15, Article 212. https://doi.org/10.1186/s12974-018-1247-9
  • Open Access
    van Scheppingen, J. G. M. (2018). Astrocytes as mediators of inflammation in epilepsy: focus on tuberous sclerosis complex. [Thesis, fully internal, Universiteit van Amsterdam].
  • van Vliet, E. A., Aronica, E., Vezzani, A., & Ravizza, T. (2018). Review: Neuroinflammatory pathways as treatment targets and biomarker candidates in epilepsy: emerging evidence from preclinical and clinical studies. Neuropathology and Applied Neurobiology, 44(1), 91-111. https://doi.org/10.1111/nan.12444
  • Open Access
    van Scheppingen, J., Mills, J. D., Zimmer, T. S., Broekaart, D. W. M., Iori, V., Bongaarts, A., Anink, J. J., Iyer, A. M., Korotkov, A., Jansen, F. E., van Hecke, W., Spliet, W. G., van Rijen, P. C., Baayen, J. C., Vezzani, A., van Vliet, E. A., & Aronica, E. (2018). miR147b: A novel key regulator of interleukin 1 beta-mediated inflammation in human astrocytes. GLIA, 66(5), 1082-1097. https://doi.org/10.1002/glia.23302
  • Open Access
    Iori, V. (2018). Epigenetic and pharmacological targeting of neuroinflammation as novel therapeutic interventions for epilepsy. [Thesis, fully internal, Universiteit van Amsterdam].
  • Aronica, E., Mühlebner, A., van Vliet, E. A., & Gorter, J. A. (2017). Characterization of pathology. In A. Pitkänen, P. S. Buckmaster, A. S. Galanopoulou, & S. L. Moshé (Eds.), Models of seizures and epilepsy (2nd ed., pp. 139-160). Academic Press. https://doi.org/10.1016/B978-0-12-804066-9.00011-0
Page 7 of 22